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Isolated ventricular non-compaction cardiomyopathy (IVNC) is a rare, morphologically distinct primary genetic cardiomyopathy,
which is now gaining prominence as an important diﬀerential diagnosis in patients presenting with cardiac failure. We describe a
casereportofaNigerianmalewithfacialdysmorphismpresentingwithcardiacfailure.Thisisfollowedbyareviewoftheliterature
with focus on the diagnosis of this condition, which may be diﬃcult especially in non-Caucasian populations.
1.Case
A 42-year-old Nigerian man presented with a three-month
history of worsening dyspnoea, orthopnoea, and paroxysmal
nocturnaldyspnoea.Hehadnoassociatedchestpain.Hehad
no signiﬁcant past medical history, was a nonsmoker, and
drank minimal alcohol. He had been living in Scotland for
severalyearsandtherewasnorecenthistoryofforeigntravel.
There was no family history of cardiomyopathy or sudden
death.
On examination he was afebrile with evidence of mild
facial dysmorphism (Figure 1). He had a resting tachycardia
with a blood pressure of 180/115. His JVP was raised, apex
beatwasimpalpable,andhehadasummationgallopwithno
murmurs.Hehadnoankleorsacraloedema.Auscultationof
his chest revealed bibasal crepitations.
He had a normal full blood count, urea, creatinine and
electrolytes, liver function and thyroid function tests. He was
HIV negative and his antinuclear factor was negative. His
electrocardiogram showed a sinus tachycardia with voltage
criteria for left ventricular hypertrophy. Troponin and CK
levels were normal. His chest X-ray showed cardiomegaly
with upper-lobe diversion. Echocardiographic images were
suboptimal in quality but showed a dilated left ventricle, and
severe global impairment of LV systolic function. Cardiac
MRI (CMR) revealed similar ﬁndings but in addition
demonstrated deep ventricular recesses and hypertrabecu-
lation of the lateral wall extending down towards the apex
(Figure 2). Unusually the true apex was not involved. The
ratio of the compacted to noncompacted myocardium was
2.6 in diastole (Figure 3). Ejection fraction was 15% and
there was no late gadolinium enhancement.
In combination with his facial dysmorphism, these
features were felt to be consistent with a diagnosis of LV
noncompaction. Given the lack of anginal symptoms or
risk factors, it was felt that coronary angiography was not
necessary. Our patient did not describe any neurological
symptoms. Furthermore complete examination of the ner-
vous system and assessment of visual acuity were normal;
therefore additional neurological investigations were not
deemed necessary.
Our patient was commenced on an ACE inhibitor,
diuretic, beta blocker, and long-term anticoagulation. We
advised him to contact his relatives back in Nigeria in order
to arrange screening investigations. On followup, he has
remained asymptomatic and has not required any further
hospitalization. Holter monitoring has proved reassuring
and repeat echocardiography suggested improvement in
function, with the ejection fraction calculated at 45%. ICD
insertion has therefore not been recommended at this time.2 Cardiology Research and Practice
Figure 1: Facial appearance of our patient. Image shows a broad
dorsum and asymmetrical tip of the nose with mild hypertelorism.
This is likely to represent a congenital craniofacial deformity.
2. Discussion
Isolatedventricularnon-compactioncardiomyopathy(IVNC)
isarare,morphologicallydistinctprimarygeneticcardiomy-
opathy, which was ﬁrst described almost two decades ago.
It is now gaining prominence as an important diﬀerential
diagnosis in patients presenting with cardiac failure. It is
characterized anatomically by prominent trabeculations in
the ventricular wall and deep intertrabecular recesses which
communicate with the main ventricular chamber [1]. This
results in a two-layered structure of compacted and non-
compacted myocardium, which allows diﬀerentiation from
normal trabeculations, false tendons, and papillary muscles.
2.1. Aetiology. IVNC appears to be a genetically inherited
condition that has been associated with many diﬀerent gene
mutations [2, 3]. Both X-linked and autosomal-dominant
inheritances have been described in diﬀerent families [4, 5].
As a result, ﬁrst-degree relatives of patients diagnosed with
IVNC require echocardiographic screening [1].
TheexactcauseofIVNC,however,remainscontroversial.
The congenital theory suggests that it is due to failure in
the compaction of the myocardium, which usually occurs
between weeks ﬁve and eight of embryonic life [6]. This
process begins in the septum and base of the heart, which
might explain why the apex and lateral are most frequently
involved in IVNC. However this hypothesis lacks proof
and is largely based upon the similarities in appearances
between the embryonic heart and IVNC. Other theories have
been proposed which include dissection of the myocardium,
frustrated attempts at hypertrophy, compensatory hyper-
vascularisation, myocardial tearing due to dilatation and
metabolic defects [7].
Nonisolated forms of non-compaction also exist which
are associated with other forms of congenital heart disease
including atrial septal defects, ventricular septal defects,
aortic stenosis, pulmonary stenosis, tricuspid stenosis, and
hypoplastic left ventricle. The aetiology of non-compaction
in non-isolated forms may be diﬀerent to IVNC [2].
2.2.AssociatedClinicalDisorders. Sincetheveryearlyreports
of non-compaction, an association has been noted with
diﬀerent forms of facial dysmorphism, particularly when
the diagnosis is made in children [2, 8–10]. IVNC is also
frequently associated with neuromuscular disorders such as
Leber’s hereditary optic neuropathy, Becker’s muscular dys-
trophy, myotonic dystrophy, and metabolic myopathy [11].
One study suggested that 80% of patients with IVNC also
had a neuromuscular disorder and neurological screening is
therefore recommended in all patients [11].
2.3. Clinical Features and Management. Dyspnoea is the
most common symptom alongside other manifestations of
cardiac failure. Cardiac arrhythmias are also frequent and
may be life threatening. The incidence of thromboembolic
events is particularly high. It is postulated that they are
the result of thrombus formation within the deep intra-
trabecular recesses. However these events are often observed
in the context of other prothrombotic factors such as atrial
ﬁbrillation and impaired systolic function [7]. In addition
the incidence of pulmonary embolism is also relatively high
[11], which suggests either involvement of the right ventricle
or a more systemic tendency to thrombosis. Anticoagulation
should be carefully considered [1] and, we believe, should
be instigated in the context of atrial ﬁbrillation, systolic
impairment, or prior embolic events.
Otherwise management of IVNC focuses on conven-
tional treatment of clinical manifestations. Patients with
decreasedventricularsystolicfunctionshouldbetreatedwith
ACE inhibitors and beta blockers [12, 13]. At the end stages
transplantation may be required [14]. Ambulatory ECG
monitoring to assess for arrhythmias is appropriate for those
with systolic dysfunction given the frequency of ventricular
tachyarrhythmias and potential risk of sudden cardiac death
[15]. Patients may require ICD insertion depending on these
results, systolic function, and family history of sudden death
[15].
Prognosis is variable; early studies suggested that it was
poor [9] but more recent studies, which have included
more subtle phenotypes, describe a much lower incidence
of death stroke or ventricular arrhythmia [12]. Predictors
of an increased mortality include increased age, neuro-
muscular disorders, cardiac failure, and left ventricular
dilatation/dysfunction [16].
2.4.Diagnosis. Giventhesigniﬁcantmorbidityandmortality
associated with IVNC, prompt and accurate recognition
by cardiac imaging techniques is essential. Until recentlyCardiology Research and Practice 3
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Figure 2: CMR images. Four chamber and short-axis views through the basal, mid-chamber, and apical segments in end diastole,
demonstrating a 2-layered compacted and non-compacted myocardium. This is observed in the free wall of the left ventricle, particularly
towards the apex although unusually the true apex is spared-. Diﬀerentiation from the papillary muscles (not shown) is made on the basis
that this structure did not communicate with the mitral valve on the long axis.
isolated IVNC was thought to be extremely rare with a
prevalence in adults of less than 0.3% [17]. However, there
has been a marked increase in the diagnosis of IVNC,
especially in asymptomatic patients. This has been attributed
to the improvements in modern imaging techniques as
well as routine screening of relatives of aﬀected patients
[18]. However, there are now concerns that IVNC may be
overdiagnosed.
Echocardiography is the ﬁrst-line investigation for
patients presenting with cardiac failure. Echocardiographic
criteria for the diagnosis of IVNC have been established
(Table 1), with the diagnosis being conﬁrmed by a ratio of
the maximal thickness of the non-compacted to compacted
layers, of greater than 2:1, in systole, in the parasternal
short-axisview.Howeverthesedeﬁnitionsarebasedonsmall
studies and are likely to be overly sensitive: in one study 25%
of all patients with LV systolic impairment referred to the
heart failure clinic fulﬁlled criteria for IVNC [19].
Cardiac MRI (CMR) is an alternative imaging technique,
which oﬀers superior contrast between the myocardium and
the blood pool. Diagnosis of IVNC can be made using CMR
and demonstration of a non-compacted:compacted ratio
>2.3, in end diastole, on long-axis views, with a sensitivity
of 86% and a speciﬁcity of 99% [20]. In this study, the
gold standard assessment against which CMR was tested was
a clinical diagnosis of IVNC. The criteria for this clinical
diagnosis ware demonstration of a two-layered myocardium
in addition to: a documented, similar appearance in a
ﬁrst-degree relative, an associated neuromuscular disorder;
regional wall motion abnormalities, or complications such4 Cardiology Research and Practice
Table 1: Echocardiographic criteria for diagnosis of IVNC.
(i) Presence of multiple echocardiographic trabeculations, particularly in the apex and free wall of the left ventricle
(ii) Multiple deep intertrabecular recesses communicating with the ventricular cavity, as demonstrated by colour Doppler imaging
(iii) A twos layered structure of the endomyocardium with a ratio of end-systolic non-compacted endocardial layer to compacted
epicardial layer of >2.0 in adults and >1.4 in children
(iv) Absence of other congenital or acquired heart disease, particularly those causing left ventricular outﬂow obstruction
Compacted
Non-compacted
Figure 3: CMR measurements of the compacted (8mm) and non-
compacted (21mm) layers of the myocardium.
as systemic emboli [20]. This highlights the diﬃculty in
studying this condition whilst deﬁnitive diagnostic criteria
are lacking.
CMR studies have also led to the realization that a lesser
degree of non-compaction may also be observed in normal
ventricles [20]. This is corroborated by autopsy ﬁndings,
which demonstrate that up to 70% of hearts display at least
one prominent left ventricular trabeculation, with two or
more present in 36% [21]. No patients had more than ﬁve,
suggesting that the number of trabeculations may be a useful
discriminatory ﬁnding [11].
Hypertrabeculation has also been reported in the context
of other forms of cardiomyopathy, most commonly in
hypertrophic cardiomyopathy and dilated cardiomyopathy.
Interesting case reports have described families, in whom the
same gene mutation has caused a dilated cardiomyopathy in
somemembersandIVNCinothers[22].Itmaybe,therefore,
that hypertrabeculation in these cardiomyopathies exists on
a spectrum, with IVNC at the extreme end.
2.5. Noncompaction in Diﬀerent Ethnic Groups. Assessment
of non-compaction is particularly diﬃcult in black patients
who display a greater degree of trabeculation of the ventricle
than other groups. In one study 13% of healthy black control
subjects fulﬁlled echo criteria for IVNC despite having no
other features suggestive of a cardiomyopathy [19].
There is in fact growing evidence that the prevalence of
IVNC diﬀers in diﬀerent ethnic groups. An Australian study
compared rates of cardiomyopathy between indigenous
and nonindigenous children and showed a much higher
incidence of IVNC in the indigenous population [23], whilst
a study based in North Africa showed that the incidence of
IVNC amongst black Africans and Arabs was again high. Of
relevance to our case, this study also described improvement
in LV function in a subgroup of patients [24].
It is unclear whether these observations reﬂect a truly
higher incidence of IVNC in these ethnic groups or are due
to oversensitivity of the diagnostic criteria, which have been
established in a predominantly Caucasian population.
2.6. Our Case. Our patient was a black African male, which
made application of existing diagnostic criteria diﬃcult.
However, the degree of hypertrabeculation in combination
with the established systolic impairment and facial dys-
morphism was in our opinion suﬃcient to make a secure
diagnosis of IVNC. It should be noted that it is unusual
for the true apex not to be involved. However this has been
described: Thuny et al. observed sparing of the true apex by
CMRin 1of the16 patients studied. All16patients, however,
had involvement of the lateral apical segment, which was the
most clearly aﬀected segment in our patient [25].
3. Conclusion
In summary, the diagnosis of IVNC is currently made
challenging because of the heterogeneity in the degree of
trabeculation observed in patients with normal ventricles
and other forms of cardiomyopathy. Current diagnostic
criteriaarebaseduponstudiesinvolvingonlyasmallnumber
of patients and there are concerns that they are leading to the
overdiagnosis of this condition. This is of particular concern
in black patients and other racial groups.
There is therefore an urgent need to establish more
stringent criteria. However, before this is possible, large
detailed studies are required to establish the normal range
of trabeculation amongst healthy subjects of diﬀerent ages
andethnicities.Onlythencanweinterpretstudiesexamining
trabeculation amongst patients with diﬀerent forms of
cardiomyopathy.
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